Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Speciallæge i hudsygdomme Eva Boné ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   5.0% 2.9% 1.5% 2.6% 1.7% 2.1% 11.5% 11.3%   Credit score (0-100)   45 59 76 60 73 67 4 4   Credit rating   BB BB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 15.8 0.0 3.0 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,550 3,695 3,558 2,932 3,297 4,194 0.0 0.0   EBITDA   274 510 1,162 1,122 1,190 2,435 0.0 0.0   EBIT   240 473 1,125 1,085 1,172 2,419 0.0 0.0   Pre-tax profit (PTP)   225.9 461.0 1,115.7 1,076.9 1,175.9 2,435.0 0.0 0.0   Net earnings   175.8 358.5 869.1 839.6 916.8 1,899.1 0.0 0.0   Pre-tax profit without non-rec. items   226 461 1,116 1,077 1,176 2,435 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   202 165 128 91.4 72.8 56.3 0.0 0.0   Shareholders equity total   117 475 1,344 404 1,185 2,184 184 184   Interest-bearing liabilities   399 258 154 229 0.0 0.0 0.0 0.0   Balance sheet total (assets)   797 1,205 2,192 1,333 1,755 3,087 184 184   Net Debt   397 -186 -1,290 -473 -664 -2,004 -184 -184     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,550 3,695 3,558 2,932 3,297 4,194 0.0 0.0   Gross profit growth   5.3% 4.1% -3.7% -17.6% 12.5% 27.2% -100.0% 0.0%   Employees   5 4 4 3 4 4 0 0   Employee growth %   0.0% -20.0% 0.0% -25.0% 33.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   797 1,205 2,192 1,333 1,755 3,087 184 184   Balance sheet change%   -11.6% 51.2% 81.9% -39.2% 31.7% 75.9% -94.0% 0.0%   Added value   274.2 509.8 1,162.1 1,121.7 1,208.6 2,435.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -31 -74 -74 -74 -37 -33 -56 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   6.8% 12.8% 31.6% 37.0% 35.5% 57.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   27.6% 47.3% 66.3% 61.6% 76.2% 100.6% 0.0% 0.0%   ROI %   40.5% 73.6% 99.2% 101.8% 129.5% 144.6% 0.0% 0.0%   ROE %   34.5% 121.2% 95.5% 96.1% 115.4% 112.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   14.6% 39.4% 61.3% 30.3% 67.5% 70.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   144.9% -36.6% -111.0% -42.2% -55.7% -82.3% 0.0% 0.0%   Gearing %   342.2% 54.3% 11.4% 56.7% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.0% 3.6% 4.6% 4.1% 0.7% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 1.3 2.3 1.2 2.7 3.2 0.0 0.0   Current Ratio   0.7 1.3 2.3 1.2 2.7 3.2 0.0 0.0   Cash and cash equivalent   1.6 444.2 1,443.7 701.9 663.6 2,004.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -206.8 223.6 1,089.7 183.5 979.6 1,981.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   55 127 291 374 302 609 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   55 127 291 374 298 609 0 0   EBIT / employee   48 118 281 362 293 605 0 0   Net earnings / employee   35 90 217 280 229 475 0 0